VIP (Vasoactive Intestinal Peptide)

Description

VIP (Vasoactive Intestinal Peptide)

VIP (Vasoactive Intestinal Peptide) is a naturally produced neuropeptide and signaling molecule that has been extensively studied for its involvement in immune regulation, inflammation management, respiratory function, digestive health, blood vessel dilation, and protection of nerve cells. It binds to receptors across the nervous, immune, and gastrointestinal systems, playing a key role in modulating cytokine levels, relaxing smooth muscle tissue, and facilitating communication between cells. Due to its wide-ranging effects throughout the body, VIP has become a focus in areas such as regenerative medicine, recovery from mold toxin exposure, autoimmune disease research, and efforts to support neuroimmune function.

Ongoing research into VIP often centers on:
– Modulation of immune responses and inflammation
– Support of respiratory and lung function
– Signaling within the gut and intestines
– Neuroprotective effects and maintaining autonomic nervous system equilibrium
– Investigation of chronic inflammatory response syndrome (CIRS)

• Status: Ongoing clinical trials for multiple conditions. Evidence level: Supported by human studies.
• Common dosage: 50–100 mcg administered intranasally each day, typically once or twice daily. Routes of administration include intranasal, intravenous infusion, and inhalation.
• Investigated uses: Autoimmune disorders, CIRS (chronic inflammatory response syndrome) or mold-related illness, and general inflammation.